PPARβ/δ Agonism with GW501516 Increases Myotube PGC-1α Content and Reduces BCAA Media Content Independent of Changes in BCAA Catabolic Enzyme Expression
Background. Type 2 diabetes is characterized by reduced insulin sensitivity, elevated blood metabolites, and reduced mitochondrial metabolism with reduced expression of genes governing metabolism such as peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α). PGC-1α regulates...
Saved in:
Main Authors: | Caroline N. Rivera, Jason S. Hinkle, Rachel M. Watne, Trent C. Macgowan, Andrew J. Wommack, Roger A. Vaughan |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-01-01
|
Series: | PPAR Research |
Online Access: | http://dx.doi.org/10.1155/2023/4779199 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The PPARδ Ligand GW501516 Reduces Growth but Not Apoptosis in Mouse Inner Medullary Collecting Duct Cells
by: Jordan Clark, et al.
Published: (2009-01-01) -
Disruption of BCAA degradation is a critical characteristic of diabetic cardiomyopathy revealed by integrated transcriptome and metabolome analysis
by: Wu Yanxia, et al.
Published: (2024-12-01) -
Higher Concentrations of BCAAs and 3-HIB Are Associated with Insulin Resistance in the Transition from Gestational Diabetes to Type 2 Diabetes
by: Ulrika Andersson-Hall, et al.
Published: (2018-01-01) -
Dysfunctional BCAA degradation triggers neuronal damage through disrupted AMPK-mitochondrial axis due to enhanced PP2Ac interaction
by: Shih-Cheng Wu, et al.
Published: (2025-01-01) -
Logarithmic matrix transformations into Gw
by: Mulatu Lemma
Published: (2004-01-01)